BALCHEM CORP
10QSB, 1997-07-30
CHEMICALS & ALLIED PRODUCTS
Previous: AUTO GRAPHICS INC, SC 13D, 1997-07-30
Next: BALL CORP, S-8, 1997-07-30



                                  FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549

                   QUARTERLY REPORT UNDER SECTION 13 OR 15(D)

                     OF THE SECURITIES EXCHANGE ACT OF 1934

FOR QUARTER ENDED JUNE 30, 1997                       COMMSSION FILE NO. 1-13648

                              BALCHEM CORPORATION


         MARYLAND                                           13-2578432
- --------------------------------------------------------------------------------
(STATE OF OTHER JURISDICTION OF                        (I.R.S EMPLOYER 
 INCORPORATION OR ORGANIZATION)                        IDENTIFICATION NUMBER) 


           PO BOX 175 SLATE HILL, NY                       10973
- --------------------------------------------------------------------------------
     (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)           (ZIP CODE)


REGISTRANTS TELEPHONE NUMBER, INCLUDING AREA CODE:      (914) 355-5300
                                                        -------------- 

INDICATE BY CHECK MARK WHETHER THE  REGISTRANT(1) HAS FILED ALL REPORTS REQUIRED
TO BE FILED BY SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING
THE  PRECEDING 12 MONTHS (OR FOR SUCH  SHORTER  PERIOD THAT THE  REGISTRANT  WAS
REQUIRED  TO FILE  SUCH  REPORTS),  AND  (2) HAS  BEEN  SUBJECT  TO SUCH  FILING
REQUIREMENTS FOR THE PAST 90 DAYS.

                     YES  [  X  ]          NO    [    ]

INDICATE THE NUMBER OF SHARES  OUTSTANDING  OF EACH OF THE  ISSUER'S  CLASSES OF
COMMON STOCK, AS OF THE CLOSE OF THE PERIOD COVERED BY THIS REPORT.

                         3,155,047 SHARES COMMON STOCK
<PAGE>
<TABLE>
<CAPTION>
                                    BALCHEM CORPORATION
                                       BALANCE SHEET



                      ASSETS
                                                                  6/30/97        6/30/96
                                                                ----------     ----------
<S>                                                             <C>            <C>
CURRENT ASSETS
    Cash & Investments ....................................        316,500         36,753
    Accounts Receivable ...................................      3,274,577      2,935,914
    Inventories ...........................................      2,315,320      1,998,383
    Prepaid Expenses ......................................        384,500        416,690
    Deferred Income Taxes .................................        174,685        137,145
                                                                ----------     ----------
       Total Current Assets ...............................      6,465,582      5,524,885
                                                                ----------     ----------

PROPERTY,PLANT & EQUIPMENT
     Land .................................................         59,690         84,710
     Building .............................................      3,819,277      4,117,916
     Equipment ............................................      8,339,863      9,951,654
                                                                ----------     ----------
      Total ...............................................     12,218,830     14,154,280
Less:Accumulated Depreciation .............................      4,822,352      6,586,303
                                                                ----------     ----------
       Net Property, Plant,Equipment ......................      7,396,478      7,567,977
                                                                ----------     ----------

OTHER ASSETS
     Intangible Assets ....................................      2,369,298        873,085
     Other ................................................         52,083         57,071
                                                                ----------     ----------
        Total Other Assets ................................      2,421,381        930,156
                                                                ----------     ----------

TOTAL ASSETS ..............................................     16,283,441     14,023,018
                                                                ==========     ==========
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                    BALCHEM CORPORATION
                                       BALANCE SHEET

                      

                      LIABILITIES & STOCKHOLDER EQUITY                       
                                                                  6/30/97        6/30/96
                                                                ----------     ----------
<S>                                                             <C>            <C>

                      
CURRENT LIABILITIES
     Payables (Trade & Accruals) ..........................      2,504,977      2,146,155
     Notes Payable ........................................                        88,442
     Short Term Revolver ..................................        155,000
     Current Portion Of Long Term Debt ....................        746,787        467,474
     Current Income Tax ...................................         64,078
                                                                ----------     ----------
       Total Current Liabilities ..........................      3,470,842      2,702,071
                                                                ----------     ----------
     Notes Payable Long Term ..............................         15,580         28,933
     Long Term Debt .......................................      1,000,000      2,098,000
     Deferred Income Tax ..................................        512,004        711,164
     Deferred  Compensation ...............................        164,788        121,572
     Other Long Term Obligations ..........................        145,950
                                                                ----------     ----------
TOTAL LIABILITIES .........................................      5,309,164      5,661,740
                                                                ----------     ----------

STOCKHOLDERS EQUITY
    Common Stock ..........................................        210,336        209,588
    Paid In Capital .......................................      1,923,920      1,768,887
    Retained Earnings .....................................      8,840,021      6,382,803
                                                                ----------     ----------
       Total Stockholders' Equity .........................     10,974,277      8,361,278
                                                                ----------     ----------

TOTAL LIABILITIES & STOCKHOLDERS' EQUITY ..................     16,283,441     14,023,018
                                                                ==========     ==========
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                                    BALCHEM CORPORATION
                                        SUMMARIZED FINANCIAL INFORMATION (UNAUDITED)
                                                      INCOME STATEMENT



                                           FOR THE SIX MONTHS ENDED                     FOR THE THREE MONTHS ENDED
                                     ---------------------------------------      --------------------------------------  
                                  6/30/97         6/30/96         % CHANGE        6/30/97           6/30/96      % CHANGE
                                 ----------      ----------       ---------       ---------         ---------      ------
<S>                              <C>             <C>              <C>             <C>               <C>            <C>
Sales & Other  Revenues ....     14,143,067      12,921,301             9.5%      7,307,924         6,664,002         9.7%

Cost Of Sales ..............      7,826,117       7,451,923                       4,061,212         3,871,162
 % Of Sales ................          55.34%          57.67%          -2.34%          55.57%            58.09%      -2.52%

Interest Expense ...........         84,293         143,320                          41,580            69,127
 % Of Sales ................           0.60%           1.11%          -0.51%           0.57%             1.04%      -0.47%

Other Expenses .............      3,851,770       3,922,987                       1,953,180         1,988,525
 % Of Sales ................          27.23%          30.36%          -3.13%          26.73%            29.84%      -3.11%
                                 ----------      ----------                       ---------         ---------      
Operating Costs And Expenses     11,762,180      11,518,230                       6,055,972         5,928,814

Pre - Tax Operating Earnings      2,380,887       1,403,071                       1,251,952           735,188
 % Of Sales ................          16.83%          10.86%           5.98%          17.13%            11.03%       6.10%
 
Income Taxes ...............        801,900         496,386                         390,076           263,109

Net Income .................      1,578,987         906,685                         861,876           472,079
 % Of Sales ................          11.16%           7.02%           4.15%          11.79%             7.08%       4.71%

Weighted Average Number Of
 Outstanding Shares ........      3,153,697       3,143,828                       3,154,257         3,143,828


     Earnings Per Share               0.501           0.288                           0.273             0.150
</TABLE>  
<PAGE>
<TABLE>
<CAPTION>
                                  BALCHEM CORPORATION
                                STATEMENT OF CASH FLOWS

                 FOR THE PERIOD ENDING JUNE 30, 1997 AND JUNE 30, 1996

                                                               1997            1996
                                                           ----------      ----------
<S>                                                        <C>             <C>
CASH FLOWS FROM OPERATING ACTIVITIES

     Net Earnings ....................................      1,578,987         906,685

Adjustment To Reconcile Net Income To
Net Cash Provided By Operating  Activities

     Deferred Taxes ..................................        (45,327)         18,390
     Depreciation & Amortization .....................        653,587         461,198

Changes In Assets & Liabilities

     Accounts Receivable .............................       (304,708)        209,578
     Inventories .....................................       (453,220)       (125,545)
     Prepaid Expenses ................................        134,216         145,476
     Accounts Payable ................................        (46,365)       (348,964)
     Income Tax  Payable .............................        (45,966)        (24,247)
     Deferred Compensation ...........................         71,546          15,910
     Other Long Term Obligation ......................        (20,000)

                                                           ----------      ----------
Total Adjustments ....................................        (56,237)        351,796

Net Cash Provided By (Used In)
Operating Activities .................................      1,522,750       1,258,481

CASH  FLOWS FROM INVESTING ACTIVITIES

     Capital Expenditures ............................       (773,506)       (210,901)
     Investments  In Other Assets ....................       (673,280)       (259,320)
     Proceeds From Sale of Property, Plant & Equipment        536,577

                                                           ----------      ----------
Net Cash Used In Investing Activities ................       (910,209)       (470,221)
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                  BALCHEM CORPORATION
                                STATEMENT OF CASH FLOWS

                 FOR THE PERIOD ENDING JUNE 30, 1997 AND JUNE 30, 1996
                                      (continued)

                                                               1997            1996
                                                           ----------      ----------
<S>                                                        <C>             <C>
CASH  FLOWS FROM  FINANCING  ACTIVITIES
     Net Borrowings Under Short Term Revolver ........        155,000
     Notes Payable ...................................                       (265,326)
     Note Payable Long Term ..........................         (6,202)         (5,586)
     Principal Payment On Long Term Debt .............       (400,000)       (528,000)
     Stock Options ...................................          8,342           6,702
     Dividends Payable ...............................       (141,887)       (109,976)

Net Cash Provided  By (Used  In)
                                                           ----------      ----------
Financing Activities .................................       (384,747)       (902,186)

                                                           ----------      ----------
INCREASE (DECREASE) IN CASH ..........................        227,794        (113,926)

CASH  BEGINNING ......................................         88,706         150,679
CASH  ENDING .........................................        316,500          36,753
                                                           ----------      ----------
</TABLE>
<PAGE>
                      Management's Discussion and Analysis 

Revenues

Total revenues for the six months ended 6/30/97 were  $14,143,067 as compared to
$12,921,301  for the six months ended 6/30/96,  an increase of $1,221,766 or 9.5
%. The increase in revenue is attributable to increased  volumes in the domestic
food encapsulation business and the specialty packaging business.

Revenues for the quarter ended 6/30/97 increased 9.7% or $643,922 as compared to
the quarter ended 6/30/96. The increase in revenue is primarily  attributable to
increased revenues generated by the specialty packaging business.

Operational Costs and Expenses

Cost of sales decreased 2.34 % as a percentage of sales for the six months ended
6/30/97 as compared to the six months  ended  6/30/96.  The  decrease in cost of
sales as a percentage of sales is partially  attributable to volume efficiencies
and partially the result of an increase in the average selling price of products
sold during the six month period.  These favorable factors were partially offset
by the  reclassification  of certain employees as well as employee benefit costs
previously  classified  as general  and  administrative  to  various  production
departments.

Cost of sales  decreased  2.52 % as a percentage  of sales for the quarter ended
6/30/97 as compared to the quarter ended 6/30/96.  The decrease in cost of sales
is partially  attributable to volume  efficiencies  and partially a result of an
increase in the average  selling  price of products  sold during the three month
period. These favorable factors were partially offset by the reclassification of
certain  employees as well as employee  benefit costs  previously  classified as
general and administrative to various production departments.

Interest  expense  decreased  .51% as a  percent  of sales or 41.1%  for the six
months ended 6/30/97 as compared to the six months ended 6/30/96.  The reduction
in interest  expense is a result of additional  principal  payments made against
the long term debt obligation  during the second quarter of 1997, the second and
third quarters of 1996 and a rate reduction obtained during the forth quarter of
1996.

Other  expenses  decreased  1.8% or 3.13% as a  percentage  of sales for the six
months ended 6/30/97 as compared to the six months ended  6/30/96.  The decrease
is partially  the result of the  reclassification  of certain  employee  benefit
costs previously  classified as general and administrative to various production
departments,  a decrease in recruiting and relocation  expense and a decrease in
office and computer  expenses  associated  with the  development of a local area
network.  These  decreases were  partially  offset by an increase in the cost of
health insurance and other employee benefit expenses.

Other expenses  decreased 1.8% or 3.11% as a percentage of sales for the quarter
ended  6/30/97 as  compared  to the  quarter  ended  6/30/96.  The  decrease  is
partiallly the result of the  reclassification of certain employee benefit costs
previously  classified  as general  anad  administrative  to various  production
departments.  The  decrease can also be  attributed  to a decrease in office and
consulting expenses associated with the development of a local area network. The
decreases were partially  offset by an increase in the cost of health  insurance
and other employee benefit expenses.
<PAGE>
Pre-Tax Earnings

Pre-tax  earnings  increased 69.7% or 5.98% as a percentage of sales for the six
months ended  6/30/97 as compared to the six months ended  6/30/96 and increased
70.3%  or 6.10% as a  percentage  of sales  for the  quarter  ended  6/30/97  as
compared to the quarter ended 6/30/96.  The increases are a direct result of the
business conditions previously described.

Inventories

Inventories  as stated for the period  6/30/97 and 6/30/96 were  $2,315,320  and
$1,998,383 respectively, inclusive of the following breakdown:

                              1997                      1996
                           ----------                ----------

Raw Materials              $1,220,469                $1,171,271
Finished Goods              1,094,851                   827,112
                           ----------                ----------
Total Inventory            $2,315,320                $1,998,383

Adjustments

In the opinion of management,  the accompanying statements are representative of
all the adjustments to fairly present the  consolidated  position as of June 30,
1997 and June 30,  1996.  Note  that  certain  prior  year  balances  have  been
reclassified to conform with current year presentation.
<PAGE>
Item 4.  Submission of Matters to a Vote of Security Holders

The annual meeting of Registrant was held on June 27, 1997.

The directors  elected at the meeting were Donald Alguire,  Kenneth Mitchell and
Israel  Sheinberg  as  Class 2  directors  and  Raymond  A.  Reber  as a Class 1
director. The other directors continuing in office are John E. Beebe, Francis X.
McDermott, Paul F. Mosher, Carl Pacifico and Leonard J. Zweifler.

The  meeting  voted on an  amendment  to Section 5 of the Stock  Option Plan for
Directors  to change  the  method of  determining  the  number of  options to be
granted  annually  to each  director  and  director  emeritus.  The  vote on the
amendment  was:  (i)  for the  amendment  2,174,574  shares,  (ii)  against  the
amendment 122,362 shares and (iii) abstaining 14,666 shares.
<PAGE>


                                    SIGNATURE


PURSUANT  TO THE  REQUIREMENT  OF  THE  SECURITIES  EXCHANGE  ACT  OF  1934  THE
REGISTRANT  HAS DULY  CAUSED  THIS  REPORT  TO BE  SIGNED  ON ITS  BEHALF BY THE
UNDERSIGNED THEREWITH DULY AUTHORIZED.




                                                       BALCHEM CORPORATION
                                                           (REGISTRANT)


                                                 BY    /S/ DINO A. ROSSI
                                                       ----------------- 
                                                       DINO A. ROSSI

                                                       VICE-PRESIDENT/
                                                       CHIEF FINANCIAL OFFICER




DATED:   JULY 30, 1997

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                         316,500
<SECURITIES>                                         0
<RECEIVABLES>                                3,274,577
<ALLOWANCES>                                         0
<INVENTORY>                                  2,315,320
<CURRENT-ASSETS>                             6,465,582
<PP&E>                                      12,218,830
<DEPRECIATION>                               4,822,353
<TOTAL-ASSETS>                              16,283,440
<CURRENT-LIABILITIES>                        3,470,842
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       210,336
<OTHER-SE>                                  10,763,940
<TOTAL-LIABILITY-AND-EQUITY>                16,283,440
<SALES>                                     14,143,067
<TOTAL-REVENUES>                            14,143,067
<CGS>                                        7,826,117
<TOTAL-COSTS>                               11,762,180
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              2,380,887
<INCOME-TAX>                                   801,900
<INCOME-CONTINUING>                          1,578,987
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,578,987
<EPS-PRIMARY>                                     .501
<EPS-DILUTED>                                     .501
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission